Table 4.
Hematological variables of lambs supplemented with curcumin.
| Item | Treatments1 |
SEM |
P-value |
||||
|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T4 | Treat | Treat × day | ||
| Erythrocytes, × 106 μL | 0.03 | 0.05 | |||||
| d 0 | 8.49 | 8.29 | 7.26 | 7.81 | 0.62 | ||
| d 7 | 6.61 | 5.88 | 7.08 | 6.47 | 0.62 | ||
| d 12 | 6.20c | 8.36b | 10.3a | 7.94b | 0.66 | ||
| d 17 | 6.56b | 7.57ab | 9.41a | 6.98b | 0.62 | ||
| Hematocrit, % | 35.2 | 33.9 | 34.7 | 34.6 | 0.48 | 0.30 | 0.21 |
| Hemoglobin, g/dL | 11.3 | 10.7 | 11.1 | 11.2 | 0.19 | 0.13 | 0.22 |
| Leukocytes, × 103/μL | 0.05 | <0.0001 | |||||
| d 0 | 10.2 | 9.98 | 9.56 | 8.58 | 0.60 | ||
| d 7 | 9.34a | 7.44b | 7.18b | 7.40b | 0.60 | ||
| d 12 | 6.57a | 5.47c | 5.85ab | 6.02ab | 0.60 | ||
| d 17 | 6.78b | 5.20c | 6.09bc | 9.92a | 0.60 | ||
| Neutrophils, × 103/μL | 0.02 | <0.0001 | |||||
| d 0 | 3.66 | 3.28 | 3.11 | 3.08 | 0.31 | ||
| d 7 | 3.99a | 2.40b | 2.37b | 2.00b | 0.31 | ||
| d 12 | 2.87a | 1.91b | 2.29ab | 1.95b | 0.35 | ||
| d 17 | 2.53b | 2.16b | 2.56b | 4.59a | 0.31 | ||
| Lymphocytes, × 103/μL | 0.33 | 0.04 | |||||
| d 0 | 5.64 | 6.23 | 6.12 | 5.16 | 0.43 | ||
| d 7 | 5.39 | 4.81 | 4.51 | 5.11 | 0.43 | ||
| d 12 | 3.52 | 3.28 | 2.70 | 3.60 | 0.49 | ||
| d 17 | 4.75a | 2.89b | 3.17b | 4.90a | 0.43 | ||
| Monocytes, × 103/μL | 0.12 | 0.11 | 0.11 | 0.13 | 0.94 | 0.94 | 0.71 |
| Eosinophils, × 103/μL | 0.09 | 0.09 | 0.10 | 0.09 | 0.02 | 0.97 | 0.84 |
a, b, c Within a row, means without out a common superscript differs (P ≤ 0.05) or tends to differ (P ≤ 0.10) between treatments.
T0, T1, T2 and T4 represents supplementation of polymethacrylate (Eudragit L-100) nanocapsules loaded with curcumin (N-CU) at 0, 1, 2 and 4 mg/kg concentrate, respectively.